BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:Stanford Cancer Institute Breakthroughs in Cancer: Defining De
 terminants of Response to Cancer Immunotherapy
X-WR-TIMEZONE:Pacific Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20260907T090620Z
UID:tag:localist.com\,2008:EventInstance_51288296744689
DTSTART:20260114T000000Z
DTEND:20260114T010000Z
DESCRIPTION:The Stanford Cancer Institute Breakthroughs in Cancer seminar s
 eries is one of the highest-profile seminar series for translational and c
 linical scientists in oncology. The series brings national leaders in canc
 er research to Stanford’s campus and highlights innovations across the s
 pectrum of basic\, translational\, clinical\, and population science. \n\n
 Join us Tuesday\, January 13\, 4-5 p.m.\, at Munzer Auditorium\, Beckman C
 enter\, or Zoom for a presentation by Lawrence Fong\, MD\, scientific dire
 ctor of the Immunotherapy Integrated Research Center (IIRC) at Fred Hutchi
 nson Cancer Center. This seminar is in memory of Wes Brown\, MD\, who dedi
 cated her career to the Stanford Blood and Marrow Transplantation & Cellul
 ar Therapy Program and its patients.\n\nDr. Fong researches the mechanisms
  of response and resistance to cancer immunotherapies in both preclinical 
 models and in cancer patients. His work helped lead to the FDA approval of
  sipuleucel-T\, an immunotherapy for prostate cancer. His research investi
 gating novel immunotherapies and combinations\, including leading the firs
 t trial of adenosine antagonism for cancer immunotherapy\, intersects with
  his role as a genitourinary oncologist treating patients with bladder can
 cer\, kidney cancer\, and prostate cancer. He has been involved with precl
 inical and clinical development of multiple immunotherapies\, including im
 mune checkpoint inhibitors that are now FDA-approved.\n\nThe event is open
  to Stanford Cancer Institute members\, postdocs\, fellows\, and students\
 , as well as Stanford University and Stanford Medicine faculty\, trainees\
 , and staff interested in basic\, translational\, clinical\, and populatio
 n-based cancer research.\n\nRegistration is encouraged.
GEO:37.431924;-122.1767
LOCATION:Beckman Center\, Munzer Auditorium
SUMMARY:Stanford Cancer Institute Breakthroughs in Cancer: Defining Determi
 nants of Response to Cancer Immunotherapy
URL;VALUE=URI:https://events.stanford.edu/event/stanford-cancer-institute-b
 reakthroughs-in-cancer-defining-determinants-of-response-to-cancer-immunot
 herapy
CATEGORIES:Class/Seminar
END:VEVENT
END:VCALENDAR